GnRH Agonist Drugs: Uses, Effects and Safety

GnRH agonists are medicines that act on the hormone system. GnRH means gonadotropin-releasing hormone, a signal made in the brain that helps control the pituitary gland and reproductive organs. With repeated treatment, an agonist changes this signalling and reduces production of sex hormones. In prostate cancer care, the aim is usually to lower testosterone stimulation of hormone-sensitive cancer cells.

The first doses can briefly stimulate hormone signalling before the longer-term suppression develops. Clinicians may use another medicine around the start of treatment when a temporary hormone rise needs to be controlled. GnRH agonists are available in forms such as injections or implants, with schedules chosen for the medicine and treatment plan. They work throughout the body rather than only at the tumour site.

These medicines are used most often within androgen deprivation therapy for prostate cancer. They may be combined with other systemic treatments, surgery or radiation according to the disease and treatment goal. A clinician may also use hormone suppression in selected situations outside oncology, but this page focuses on its cancer-care role.

Alternative hormone strategies can include medicines that block the androgen receptor, medicines that reduce hormone production through another route, or surgery that removes the main source of testosterone. These options differ in timing, side effects, reversibility and practical demands. The choice depends on cancer features, other health conditions, previous treatment and your preferences.

Lower testosterone can affect hot flushes, sexual interest, erections, energy, mood and muscle strength. Some people notice changes in weight or bone health over time. Your team may discuss movement, nutrition, bone protection and monitoring of metabolic or cardiovascular health. Report new or worsening symptoms, especially severe mood changes, chest symptoms or sudden weakness, so they can be assessed promptly.

The treatment schedule can continue for an extended period, depending on the cancer and the intended benefit. Keep injection appointments and tell the team about medicines and health conditions. Do not stop treatment without discussing it, because hormone levels can change and the cancer plan may be affected. Ask how bone health, blood tests and symptoms will be followed during therapy.